Tatva Chintan Pharma Chem Limited | Globe Capital
Tatva Chintan Pharma Chem Limited
Closed
Price Band
Rs. 1073 – 1083
IPO Issue Period
Jul 16, 2021 to Jul 20, 2021
Issue Size
Rs. 500 Cr.
Face value
Rs. 10/-
Fresh issue
Rs. 225 Cr.
Offer for sale
Rs. 275 Cr.
Minimum Shares for Retail
13 shares
Maximum Shares for Retail
182 shares
Listing on
NSE, BSE
Issue Type
Book Building
QIB
Not More than 50% of the offer
NII
Not less than 15% of the offer
Retail
Not less than 35% of the offer
Registrar to the Issue
Link Intime India Private Ltd

ICICI Securities Limited, JM Financial Consultants Private Limited

Tatva Chintan Pharma Chem Limited was incorporated on June 12, 1996. It is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). It is among the largest manufacturer of SDAs for zeolites in India. The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations. Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat. Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

For year/ period ended ( in Cr.)

31 Mar 2021 31 Mar 2020 31 Mar 2019
Total Revenue 300.36 263.24 206.31
Profit After Tax 52.26 37.76 20.54
EPS 26.02 18.81 10.23
OPM(%) 23.2% 21.4% 16.63%
PATM(%) 17.4% 14.36% 9.96%
  • The Company is a leading manufacturer of structure directing agents and phase transfer catalyst.
  • It has diversified specialised product portfolio requiring strong technical know-how.
  • Global presence with a wide customer base across various industries having high entry barriers
  • Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
  • Experienced promoters and managers team.
  • Strong financial performance track record.
  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.

The company is in a fast forward mode and the issue is reasonably priced. The green chemical industry is fancied by investors across the board. Investment may be considered for short to long term rewards. Hence, investor can subscribe to the issue for the medium to long-term.

Open Account